| Logo | Name | Σ | ||
|---|---|---|---|---|
 | SAYENS [Automatic translation follows] INNOVATION CATALYST SATT SAYENS is a simplified joint stock company (SAS) whose shareholders are Bpifrance, the University of Burgundy, the University of Franche-Comté, the University of Lorraine, the Technological University of Troyes, the Agro Dijon Institute, the University of Technology of Belfort Montbéliard, the ENSMM, the CNRS and Inserm. The 2 main activities of SATT SAYENS: - investment in intellectual property and the maturation of innovations from research laboratories in its territory, - as well as the management of partnership research on behalf of the research laboratories of the University of Burgundy and the Agro Dijon Institute. … Tags: SATT Network Sectors: | 231 | 68 | 138 |
 | Région Grand Est [Automatic translation follows] Dynamic, competitive and innovative, the Grand Est Region is at your side and at your service. Priorities → #Employment #Digital #Youth #Territories #Mobility #Europe Find us on https://www.grandest.fr/ Also follow the news on our social networks: - Twitter: @regiongrandest - Facebook: @regiongrandest - Instagram: @laregiongrandest local authority Sectors: | 2182 | 1805 | 280 |
 | BioValley France Pôle de compétitivité santé du Grand Est Pôle de compétitivité Santé du Grand Est, BioValley France (ex Alsace BioValley) a pour mission de fédérer, développer et faire rayonner les acteurs de la filière à travers l’Innovation. Le Pôle s’appuie sur un réseau dynamique d’entreprises, une recherche académique et clinique de premier plan, ainsi qu’un réseau intégré de partenaires, acteurs-clés de l’innovation. BioValley France accompagne ses membres dans leur démarche d’Innovation R&D et leur permet d’accéder à des expertises à forte valeur ajoutée, dans une approche marché. BioValley France participe activement aux projets structurants et collaboratifs du territoire. Il contribue notamment … Sectors: | 401 | 155 | 308 |
 | PMT [Automatic translation follows] Innovation Catalyst & Business Accelerator in BFC A competitiveness cluster since 2005, the PMT catalyzes innovation, accelerates business and supports industry transitions in Bourgogne-Franche-Comté. Since 2017, it has brought together, through its PMT Santé and PMT ASD clusters, the health technology sectors on the one hand and the aeronautics-space-defense sectors on the other, resulting from excellence in microtechnology. It has also developed strong expertise in support dedicated to start-ups and innovative companies through its PMT Propulseur accelerator. Microtechnology, Health, Aeronautics, Defense, Space, Precision mechanics, Luxury, Innovation, International, Labeling, Training, Medical, Bourgogne-Franche-Comté, and Precision mechanics Sectors: | 290 | 84 | 245 |
 | TEMIS Technopole [Automatic translation follows] Benefit from an expert system for innovation in Biotechs, Medtechs and industry 4.0. The TEMIS technology park is an ecosystem in Besançon by bringing together and promoting synergies between the economic, academic, scientific and training sectors to generate ideas and innovation projects. The Besançon technology park offers 250 ha of know-how on 2 sites: TEMIS Santé specializing in biomedical, biotherapies and bioproduction... with the BIO INNOVATION center as the embodiment of the current dynamics. A point of contact for accessing the resources, equipment, expertise and know-how essential to defining and conducting projects relating to the medicine of … | 41 | 14 | 24 |
 | Leem [Automatic translation follows] The professional organization of pharmaceutical companies operating in France. Leem, Les Entreprises du médicament, brings together companies in the pharmaceutical industry sector in France. Created over 130 years ago, Leem now has nearly 270 member companies, which generate nearly 98% of the total pharmaceutical turnover in France. The pharmaceutical industry employs 100,000 people in over 150 professions, and has recruited 10,000 employees per year for the past 10 years. Each year, the pharmaceutical industry invests 12% of its turnover in research, in order to develop new innovative treatments. It brings together more than 20,000 people in its … Sectors: | 717 | 383 | 261 |
 | Caisse d’Epargne [Automatic translation follows] Cooperative banks, the Caisses d'Epargne have been combining trust, solidarity and modernity since 1818. The second largest banking network in France, the 16 regional Caisses d'Epargne are among the leading banks in their region. They support all economic players and are leaders in financing the public sector, social housing and the social economy. In total, the Caisses d'Epargne now have 4.8 million members and 20.6 million customers, managed by the 4,182 bank branches and the Mon banquier en ligne agency. | 2151 | 1551 | 747 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 828 | 483 | 507 |
 | La French Tech Est La French Tech Est: the collective of entrepreneurs, startups, and tech actors in the Grand Est region. La French Tech Est one of the 17 @LaFrenchTech 🐓🇫🇷 Capitals. A collective of entrepreneurs and stakeholders for entrepreneurs. Initially recognized as a French Tech Metropolis in 2015 and later designated as a French Tech Capital in 2019, the La French Tech Est association is chaired by entrepreneurs who build actions, operations, and events for entrepreneurs and project leaders in the region. Our goal is to implement the necessary measures and programs to make startups in the region high-potential growth companies, creating employment … Sectors: | 601 | 220 | 426 |
 | NEFTYS [Automatic translation follows] Neftys, the leading alternative financing fintech for innovative start-ups and SMEs Neftys is the leading business financing platform in France (1,900+ transactions completed for a cumulative total of €1 billion - figures as of 01/01/2024). Our mission is to help business creators and managers secure and accelerate their research investments. With our exclusive PREFICIR® system, we offer start-ups and SMEs an immediate cash advance on their Research Tax Credit, in order to finance the time lag between the commitment of research expenses and the benefit of the CIR, a period which can reach 12 to 18 months … Sectors: | 288 | 22 | 286 |
 | CCI Alsace Eurométropole [Automatic translation follows] The 1st business accelerator The CCI Alsace Eurométropole is a public institution managed by 30 volunteer business leaders elected for 5 years. It represents the 90,000 companies in industry, commerce and services in Alsace. It actively participates in the development of the local economy. Our actions are structured around major missions: - Represent the interests of companies. - Support business creators and buyers. - Mobilize our expertise and our networking capacity to support our companies' projects throughout their life. - Deploy an initial, continuing or apprenticeship training offer, in particular thanks to our CCI Campus training center. … Sectors: | 367 | 272 | 114 |
 | Celgene We have merged with Bristol Myers Squibb creating a leading biopharma company, ideally positioned to discover, develop and deliver innovative medicines for patients fighting serious diseases. Visit www.bms.com to continue to learn more about our work to produce the next generation of medicines to treat cancer and other serious diseases. For more information on the acquisition, see our press release at: http://bit.ly/3UbQcnl Hematology, Oncology, Inflammation, Immunology, Cancer, R&D, Innovation, Immunooncology, biopharma, Epigenetics, Protein Homeostasis, Translation Medicine, and Orphan diseases Sectors: | 8 | 7 | 0 |
 | Ministère de l'Enseignement supérieur et de la Recherche [Automatic translation follows] The priorities of the Ministry of National Education, Higher Education and Research are: - to improve student success and promote equal opportunities; - to coordinate the training offer of French higher education; - to set priority areas for the progress of knowledge and technologies; - as well as the public research and innovation strategy. In this context, the so-called "ESR" law of July 22, 2013 also advocates transformation and openness to all forms of teaching and research, to the socio-economic environment, and to the international. Among the key measures put in place: - The definition of a … | 1399 | 1027 | 172 |
 | Groupe TF1 [Automatic translation follows] Welcome to a world of content The TF1 group is a global player in the production, editing and distribution of content. Through its content, its ambition is to inspire society positively. The TF1 group organizes its activities in several additional poles: • The Broadcast pole with 5 clear channels (TF1, TMC, TFX, TF1 Films series, LCI), 4 thematic channels (Ushuaia TV, TV history, Breizh TV, Club series), 2 content platforms on demand (MyTF1, Tfou max), and the TF1 advertising. • The production center with Newen, which brings together 9 studios in France and internationally. • The digital … Sectors: | 4988 | 3993 | 247 |
Research